塞德罗尔可以通过骨髓分化因子2介导的炎症抑制,通过屏障恢复和微生物群调节来改善性结肠炎
Yi-Qing Zhao1, Yu Zhang1, Yan Qin1
1Department of Gastroenterology, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan 030012, Shanxi Province, China.
醇 (CE) 通过减少炎症和修复肠道屏障,有效治疗性结肠炎. 它针对TLR4/MD2复合体,重新平衡肠道微生物群,并显示出这种慢性疾病的治疗潜力.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,需要新的治疗方法.
- 醇 (CE) 是一种天然化合物,具有抗炎和抗氧化特性,但其UC疗效尚不清楚.
研究的目的:
- 研究Cedrol (CE) 在性结肠炎 (UC) 的治疗潜力和机制.
主要方法:
- 在小鼠结肠炎模型中评估了CE的抗炎和屏障修复作用.
- 采用网络药理学,分子对接和模拟来识别CE目标.
- 在体外验证了抗炎机制,并分析了肠道微生物群的组成.
主要成果:
- CE显著缓解了结肠炎症状,减少了炎症,并恢复了肠道屏障的完整性.
- CE抑制了脂聚糖诱导的TLR4/MD2信号传递,抑制了下游的炎症途径.
- CE逆转了大肠炎引起的肠道失调,丰富了像Christensenella minuta.这样的有益细菌.
结论:
- 塞德罗尔 (CE) 通过向MD2受体来抑制与UC相关的炎症.
- CE促进粘膜屏障的修复和调节肠道微生物群,支持其在UC的治疗应用.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
06:19Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
04:06Using Fluorescence-Mediated Tomography to Assess Murine Intestinal Inflammation
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
